Direct effects of type I interferons on cells of the immune system - PubMed (original) (raw)
Review
. 2011 May 1;17(9):2619-27.
doi: 10.1158/1078-0432.CCR-10-1114. Epub 2011 Mar 3.
Affiliations
- PMID: 21372217
- DOI: 10.1158/1078-0432.CCR-10-1114
Free article
Review
Direct effects of type I interferons on cells of the immune system
Sandra Hervas-Stubbs et al. Clin Cancer Res. 2011.
Free article
Abstract
Type I interferons (IFN-I) are well-known inducers of tumor cell apoptosis and antiangiogenesis via signaling through a common receptor interferon alpha receptor (IFNAR). IFNAR induces the Janus activated kinase-signal transducer and activation of transcription (JAK-STAT) pathway in most cells, along with other biochemical pathways that may differentially operate, depending on the responding cell subset, and jointly control a large collection of genes. IFNs-I were found to systemically activate natural killer (NK) cell activity. Recently, mouse experiments have shown that IFNs-I directly activate other cells of the immune system, such as antigen-presenting dendritic cells (DC) and CD4 and CD8 T cells. Signaling through the IFNAR in T cells is critical for the acquisition of effector functions. Cross-talk between IFNAR and the pathways turned on by other surface lymphocyte receptors has been described. Importantly, IFNs-I also increase antigen presentation of the tumor cells to be recognized by T lymphocytes. These IFN-driven immunostimulatory pathways offer opportunities to devise combinatorial immunotherapy strategies.
©2011 AACR.
Similar articles
- Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
Gattoni A, Parlato A, Vangieri B, Bresciani M, Derna R. Gattoni A, et al. Clin Ter. 2006 Jul-Aug;157(4):377-86. Clin Ter. 2006. PMID: 17051976 Retracted. Review. - [Interferon signaling pathways].
Gongora C, Mechti N. Gongora C, et al. Bull Cancer. 1999 Nov;86(11):911-9. Bull Cancer. 1999. PMID: 10586107 French. - Mechanisms of type I interferon signaling in normal and malignant cells.
Li Y, Srivastava KK, Platanias LC. Li Y, et al. Arch Immunol Ther Exp (Warsz). 2004 May-Jun;52(3):156-63. Arch Immunol Ther Exp (Warsz). 2004. PMID: 15247882 Review. - Interferon-β induces apoptosis in human SH-SY5Y neuroblastoma cells through activation of JAK-STAT signaling and down-regulation of PI3K/Akt pathway.
Dedoni S, Olianas MC, Onali P. Dedoni S, et al. J Neurochem. 2010 Dec;115(6):1421-33. doi: 10.1111/j.1471-4159.2010.07046.x. Epub 2010 Nov 11. J Neurochem. 2010. PMID: 21044071
Cited by
- Type I interferon signaling pathway enhances immune-checkpoint inhibition in KRAS mutant lung tumors.
Fernández-García F, Fernández-Rodríguez A, Fustero-Torre C, Piñeiro-Yáñez E, Wang H, Lechuga CG, Callejas S, Álvarez R, López-García A, Esteban-Burgos L, Salmón M, San Román M, Guerra C, Ambrogio C, Drosten M, Santamaría D, Al-Shahrour F, Dopazo A, Barbacid M, Musteanu M. Fernández-García F, et al. Proc Natl Acad Sci U S A. 2024 Sep 3;121(36):e2402913121. doi: 10.1073/pnas.2402913121. Epub 2024 Aug 26. Proc Natl Acad Sci U S A. 2024. PMID: 39186651 - VHL loss enhances antitumor immunity by activating the anti-viral DNA-sensing pathway.
Jiao M, Hu M, Pan D, Liu X, Bao X, Kim J, Li F, Li CY. Jiao M, et al. iScience. 2024 Jun 15;27(7):110285. doi: 10.1016/j.isci.2024.110285. eCollection 2024 Jul 19. iScience. 2024. PMID: 39050705 Free PMC article. - The interferon-regulated host factor hnRNPA0 modulates HIV-1 production by interference with LTR activity, mRNA trafficking, and programmed ribosomal frameshifting.
Roesmann F, Sertznig H, Klaassen K, Wilhelm A, Heininger D, Heß S, Elsner C, Marschalek R, Santiago ML, Esser S, Sutter K, Dittmer U, Widera M. Roesmann F, et al. J Virol. 2024 Jul 23;98(7):e0053424. doi: 10.1128/jvi.00534-24. Epub 2024 Jun 20. J Virol. 2024. PMID: 38899932 - Dysregulation of base excision repair factors associated with low tumor immunogenicity in head and neck cancer: implication for immunotherapy.
Shpilman Z, Kidane D. Shpilman Z, et al. Ther Adv Med Oncol. 2024 Apr 25;16:17588359241248330. doi: 10.1177/17588359241248330. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 38680291 Free PMC article. - Interferons and interferon-related pathways in heart disease.
Tran DT, Batchu SN, Advani A. Tran DT, et al. Front Cardiovasc Med. 2024 Apr 11;11:1357343. doi: 10.3389/fcvm.2024.1357343. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38665231 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials